BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
629 results:

  • 1. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment.
    Raguz J; Pinto C; Pölzlbauer T; Habbeddine M; Rosskopf S; Strauß J; Just V; Schmidt S; Bidet Huang K; Stemeseder F; Schippers T; Stewart E; Jez J; Berraondo P; Orlinger KK; Lauterbach H
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631709
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Reprogramming Chromosome Ends by Functional Histone Acetylation.
    Meltzer WA; Gupta A; Lin PN; Brown RA; Benyamien-Roufaeil DS; Khatri R; Mahurkar AA; Song Y; Taylor RJ; Zalzman M
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612707
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LymphoDose: a lymphocyte dose estimation framework-application to brain radiotherapy.
    de Kermenguy F; Benzazon N; Maury P; Vauclin R; M'hamdi M; Cifliku V; Limkin E; Diallo I; Morel D; Milewski C; Clémenson C; Mondini M; Deutsch E; Robert C
    Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38593817
    [No Abstract]    [Full Text] [Related]  

  • 4. Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma.
    He Y; Liu L; Dong Y; Zhang X; Song Y; Jing Y; Ni Y; Wang Y; Wang Z; Ding L
    Cancer Immunol Immunother; 2024 Mar; 73(5):78. PubMed ID: 38554152
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. BRG1 mediates epigenetic regulation of TNFα-induced CCL2 expression in oral tongue squamous cell carcinoma cells.
    Xu M; Lu X; Zhu F; Sun X; Yao H; Zhang J; Chen W; Zhu H; Liu F; Shi SL; Deng X
    J Cell Biochem; 2024 Apr; 125(4):e30535. PubMed ID: 38348687
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review.
    Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O
    J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Methylation of histone H3 lysine 36 is a barrier for therapeutic interventions of head and neck squamous cell carcinoma.
    Caeiro LD; Nakata Y; Borges RL; Zha M; Garcia-Martinez L; Bañuelos CP; Stransky S; Liu T; Chan HL; Brabson J; Domínguez D; Zhang Y; Lewis PW; Aznar Benitah S; Cimmino L; Bilbao D; Sidoli S; Wang Z; Verdun RE; Morey L
    Genes Dev; 2024 Feb; 38(1-2):46-69. PubMed ID: 38286657
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.
    Wu H; Liu C; Yuan Q; Qiao Y; Ding Y; Duan L; Li W; Zhang M; Zhang X; Jiang Y; Lu J; Dong Z; Wang T; Liu K; Zhao J
    Oncoimmunology; 2023; 12(1):2282250. PubMed ID: 38126034
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
    Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
    Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. fgfr1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.
    Chu YH; Mullaney K; DiNapoli SE; Cohen MA; Xu B; Ghossein R; Katabi N; Dogan S
    Histopathology; 2024 Mar; 84(4):589-600. PubMed ID: 38010295
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Elevation of H3K27me3 level contributes to the radioresistance of nasopharyngeal carcinoma by inhibiting OAS1 expression.
    Zhou Y; Xiao Y; Liu H; Chen Q; Zhu L; Zeng L; Liu X; Pan Y; Zhang J; Fu J; Shao C
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C60-C73. PubMed ID: 38009194
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Employing Noble Metal-Porphyrins to Engineer Robust and Highly Active Single-Atom Nanozymes for Targeted Catalytic Therapy in Nasopharyngeal Carcinoma.
    Wang D; Wang J; Gao XJ; Ding H; Yang M; He Z; Xie J; Zhang Z; Huang H; Nie G; Yan X; Fan K
    Adv Mater; 2024 Feb; 36(7):e2310033. PubMed ID: 37994246
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. KIFC1 promotes proliferation and pseudo-bipolar division of ESCC through the transportation of Aurora B kinase.
    Du B; Wei L; Wang J; Li Y; Huo J; Wang J; Wang P
    Aging (Albany NY); 2023 Nov; 15(21):12633-12650. PubMed ID: 37955677
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC.
    Chen B; Zheng K; Fang S; Huang K; Chu C; Zhuang J; Lin J; Li S; Yao H; Liu A; Liu G; Lin J; Lin X
    J Nanobiotechnology; 2023 Oct; 21(1):378. PubMed ID: 37848956
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma.
    Ludwig ML; Michmerhuizen NL; Wang J; Birkeland AC; Majchrowski BK; Nimmagadda S; Zhai J; Bhangale A; Kulkarni A; Jiang H; Swiecicki PL; Brenner JC
    Arch Oral Biol; 2023 Dec; 156():105822. PubMed ID: 37844343
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma.
    Nguyen Vu TH; Kikuchi O; Ohashi S; Saito T; Ida T; Nakai Y; Cao Y; Yamamoto Y; Kondo Y; Mitani Y; Kataoka S; Kondo T; Katada C; Yamada A; Matsubara J; Muto M
    Cancer Sci; 2023 Dec; 114(12):4664-4676. PubMed ID: 37724648
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer.
    Modestino L; Cristinziano L; Poto R; Ventrici A; Trocchia M; Ferrari SM; Fallahi P; Paparo SR; Marone G; Antonelli A; Varricchi G; Galdiero MR
    Front Immunol; 2023; 14():1167404. PubMed ID: 37705974
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Combination
    Gunda V; Ghosh C; Hu J; Zhang L; Zhang YQ; Shen M; Kebebew E
    Thyroid; 2023 Oct; 33(10):1201-1214. PubMed ID: 37675898
    [No Abstract]    [Full Text] [Related]  

  • 19. Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma.
    Mann JE; Smith JD; Kulkarni A; Foltin SK; Scheftz EB; Murray IR; Gensterblum-Miller E; Brummel CV; Bhangale A; Hoesli RC; Brenner JC
    Oral Oncol; 2023 Nov; 146():106562. PubMed ID: 37666053
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic analysis and treatment utilization of different treatment strategies in elderly esophageal cancer patients with distant metastases: a SEER database analysis.
    Han LQ; Cui TT; Xiao NJ; Li W
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15413-15423. PubMed ID: 37644234
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 32.